Medicine and Health

PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial

T. B. Dorff, M. S. Blanchard, et al.

A groundbreaking phase 1 study explores PSCA-directed CAR T cells in men with metastatic castration-resistant prostate cancer (mCRPC), revealing potential declines in PSA and radiographic improvements, despite safety challenges. This innovative research was conducted by a dedicated team of authors, including Tanya B. Dorff and M. Suzette Blanchard.

00:00

Playback language: English

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy

M. J. V. D. Doelen, I. M. Oving, et al.

Medicine and Health

Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial

B. Besse, E. Pons-tostivint, et al.

Medicine and Health

Locoregional delivery of IL-13Rx2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial

C. E. Brown, J. C. Hibbard, et al.

Medicine and Health

CAR T-Cell Therapy for Cancer: Latest Updates and Challenges, with a Focus on B-Lymphoid Malignancies and Selected Solid Tumours

H. K. Tang, C. Tang, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny